Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us ![]()
About
Natural Product Expo W...Natural Product Expo West
Not Confirmed
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Not Confirmed
Not Confirmed
03-06 March, 2026
Pharma & Device Packag...Pharma & Device Packaging
Not Confirmed
Not Confirmed
04-05 March, 2026
List your booth number for exhibitions, ask us
CONTACT DETAILS






Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Natural Product Expo W...Natural Product Expo West
Industry Trade Show
Not Confirmed
03-06 March, 2026
Natural Products ExpoNatural Products Expo
Industry Trade Show
Not Confirmed
03-06 March, 2026
Pharma & Device Packag...Pharma & Device Packaging
Industry Trade Show
Not Confirmed
04-05 March, 2026
Digital content

08 Jan 2026
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2026/01/08/3215208/0/en/Enara-Bio-Enters-2026-with-Dark-Antigen-Licensing-to-Boehringer-Ingelheim-Appointment-of-Chief-Medical-Officer-and-Plans-to-Advance-DARKFOX-T-cell-Engager-into-First-in-Human-Studi.html

04 Nov 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/11/04/3180455/0/en/Enara-Bio-s-DARKFOX-Discovery-Propels-ENA101-the-First-Ever-Bispecific-T-Cell-Engager-Targeting-a-Cancer-Specific-Dark-Antigen-into-IND-Enabling-Studies.html

06 Oct 2025
// PHARMAWEB
https://www.pharmiweb.com/press-release/2025-10-06/enara-bio-to-reveal-darkfox-a-novel-cancer-specific-dark-antigen-with-broad-ranging-therapeutic-potential-in-oral-presentation-at-sitc-2025

03 Oct 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/10/03/3160977/0/en/Enara-Bio-to-Reveal-DARKFOX-a-Novel-Cancer-Specific-Dark-Antigen-with-Broad-Ranging-Therapeutic-Potential-in-Oral-Presentation-at-SITC-2025.html

01 May 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/05/01/3072084/0/en/Enara-Bio-Strengthens-Senior-Leadership-with-Key-Executive-and-Board-Appointments-Alongside-Acceleration-of-Multiple-T-Cell-Engager-Programs.html

03 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/03/2957454/0/en/Enara-Bio-raises-32-5-million-Series-B-financing-to-advance-first-in-class-pipeline-of-TCR-based-immunotherapies-targeting-novel-Dark-Antigens.html
ABOUT THIS PAGE